Pfizer picks up Brazil's Teuto in $240M deal

Pfizer will pay $240 million for a 40 percent stake in Brazil's Laboratorio Teuto Brasileiro, a generics specialist, as it expands further in emerging markets. Report

Suggested Articles

tecentriq
Pharma

Roche's Tecentriq scores first-in-class liver cancer nod

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

by Carly Helfand
abbvie
Pharma

AbbVie scores 'game-changer' nod for Oriahnn in uterine fibroids

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

by Carly Helfand
Pharma

Sanofi loses vaccines chief Loew to Ipsen amid C-suite shakeup

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.

by Angus Liu